Cargando…
HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
Hepatocyte cell adhesion molecule (HepaCAM) is a tumour suppressor. However, the mechanism of HepaCAM function in prostate cancer (PCa) remains unknown. In the present study, HepaCAM, androgen receptor (AR) and Ran were analysed in 46 PCa tissue samples using immunohistochemistry. Subsequently, the...
Autores principales: | Deng, Qingfu, Luo, Li, Quan, Zhen, Liu, Nanjing, Du, Zhongbo, Sun, Wei, Luo, Chunli, Wu, Xiaohou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390061/ https://www.ncbi.nlm.nih.gov/pubmed/30664187 http://dx.doi.org/10.3892/mmr.2019.9841 |
Ejemplares similares
-
HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
por: Deng, Qingfu, et al.
Publicado: (2022) -
Functional significance of the hepaCAM gene in bladder cancer
por: He, Yunfeng, et al.
Publicado: (2010) -
Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM
por: Li, Ting, et al.
Publicado: (2020) -
HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro
por: Du, Zhongbo, et al.
Publicado: (2018) -
HepaCAM-PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation
por: He, Zhenting, et al.
Publicado: (2022)